U.S. Nootropics Market (2025 - 2030) Size, Share & Trends Analysis Report By Product (Natural, Synthetic), By Form (Powder, Drinks, Gummies), By Application, By Distribution Channel, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Market Definition
                    1.3. Information Procurement
                        1.3.1. Purchased Database
                        1.3.2. GVR’s Internal Database
                        1.3.3. Secondary Sources & Third-Party Perspectives
                        1.3.4. Primary Research
                    1.4. Information Analysis
                        1.4.1. Data Analysis Models
                    1.5. Market Formulation & Data Visualization
                    1.6. Data Validation & Publishing
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Product Outlook
                    2.3. Form Outlook
                    2.4. Application Outlook
                    2.5. Distribution Channel Outlook
Chapter 3. U.S. Nootropics Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                    3.2. Industry Value Chain Analysis
                        3.2.1. Raw Material Outlook
                        3.2.2. Manufacturing & Technology Outlook
                        3.2.3. Profit Margin Analysis
                    3.3. Market Dynamics
                        3.3.1. Market Driver Analysis
                        3.3.2. Market Restraint Analysis
                        3.3.3. Market Opportunities
                        3.3.4. Market Challenges
                    3.4. Industry Analysis - Porter’s Five Forces Analysis
                    3.5. Market Entry Strategies
Chapter 4. U.S. Nootropics Market: Product Estimates & Trend Analysis
                    4.1. U.S. Nootropics Market, By Product: Key Takeaways
                    4.2. Product Movement Analysis & Market Share, 2024 & 2030
                    4.3. Market Estimates & Forecasts, by Product, 2018 - 2030 (USD Million)
                        4.3.1. Natural
                            4.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
                        4.3.2. Synthetic
                            4.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 5. U.S. Nootropics Market: Form Estimates & Trend Analysis
                    5.1. U.S. Nootropics Market, By Form: Key Takeaways
                    5.2. Form Movement Analysis & Market Share, 2024 & 2030
                    5.3. Market Estimates & Forecasts, by Form, 2018 - 2030 (USD Million)
                        5.3.1. Capsules/Tablets
                            5.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
                        5.3.2. Powder
                            5.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
                        5.3.3. Drinks
                            5.3.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
                        5.3.4. Gummies
                            5.3.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
                        5.3.5. Others (Liquid, patches, and novel delivery methods)
                            5.3.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 6. U.S. Nootropics Market: Application Estimates & Trend Analysis
                    6.1. U.S. Nootropics Market, By Application: Key Takeaways
                    6.2. Application Movement Analysis & Market Share, 2024 & 2030
                    6.3. Market Estimates & Forecasts, by Application, 2018 - 2030 (USD Million)
                        6.3.1. Cognitive Enhance
                            6.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
                        6.3.2. Mood & Stress Management
                            6.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
                        6.3.3. Sleep Optimization
                            6.3.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
                        6.3.4. Energy & Physical Performance
                            6.3.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
                        6.3.5. Others (Microcirculation, Anti-Aging & Longevity, Social Anxiety & Confidence Enhancement, Creativity boosting)
                            6.3.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 7. U.S. Nootropics Market: Distribution Channel Estimates & Trend Analysis
                    7.1. U.S. Nootropics Market, By Distribution Channel: Key Takeaways
                    7.2. Distribution Channel Movement Analysis & Market Share, 2024 & 2030
                    7.3. Market Estimates & Forecasts, by Form, 2018 - 2030 (USD Million)
                        7.3.1. Offline
                            7.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
                        7.3.2. Online
                            7.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 8. Competitive Analysis
                    8.1. Recent developments & impact analysis, by key market participants
                    8.2. Company Categorization
                    8.3. Participant’s Overview
                    8.4. Financial Performance
                    8.5. Product Benchmarking
                    8.6. Company Market Share Analysis, 2024 (%)
                    8.7. Company Heat Map Analysis
                    8.8. Strategy Mapping
                    8.9. Company Profiles
                        8.9.1. Qualia Life Sciences, LLC
                            8.9.1.1. Company Overview
                            8.9.1.2. Financial Performance
                            8.9.1.3. Product Portfolios
                            8.9.1.4. Strategic Initiatives
                        8.9.2. Unilever (Onnit Labs, Inc.)
                            8.9.2.1. Company Overview
                            8.9.2.2. Financial Performance
                            8.9.2.3. Product Portfolios
                            8.9.2.4. Strategic Initiatives
                        8.9.3. GNC Holdings, LLC
                            8.9.3.1. Company Overview
                            8.9.3.2. Financial Performance
                            8.9.3.3. Product Portfolios
                            8.9.3.4. Strategic Initiatives
                        8.9.4. Performance Lab USA Corp.
                            8.9.4.1. Company Overview
                            8.9.4.2. Financial Performance
                            8.9.4.3. Product Portfolios
                            8.9.4.4. Strategic Initiatives
                        8.9.5. NeuroGum, Inc.
                            8.9.5.1. Company Overview
                            8.9.5.2. Financial Performance
                            8.9.5.3. Product Portfolios
                            8.9.5.4. Strategic Initiatives
                        8.9.6. Natural Stacks
                            8.9.6.1. Company Overview
                            8.9.6.2. Financial Performance
                            8.9.6.3. Product Portfolios
                            8.9.6.4. Strategic Initiatives
                        8.9.7. Nootropics Depot
                            8.9.7.1. Company Overview
                            8.9.7.2. Financial Performance
                            8.9.7.3. Product Portfolios
                            8.9.7.4. Strategic Initiatives
                        8.9.8. BrainMD Health
                            8.9.8.1. Company Overview
                            8.9.8.2. Financial Performance
                            8.9.8.3. Product Portfolios
                            8.9.8.4. Strategic Initiatives
                        8.9.9. Reckitt Benckiser Group PLC (Schiff RB Health (US) LLC)
                            8.9.9.1. Company Overview
                            8.9.9.2. Financial Performance
                            8.9.9.3. Product Portfolios
                            8.9.9.4. Strategic Initiatives
                        8.9.10. NOW Foods.
                            8.9.10.1. Company Overview
                            8.9.10.2. Financial Performance
                            8.9.10.3. Product Portfolios
                            8.9.10.4. Strategic Initiatives

List of Tables

Table 1 U.S. nootropics market - Key market driver analysis
Table 2 U.S. nootropics market - Key market restraint analysis
Table 3 U.S. nootropics market estimates & forecast, by product (USD Million)
Table 4 U.S. Natural nootropics market estimates and forecast, 2018 - 2030 (USD Million)
Table 5 U.S. Synthetic nootropics market estimates and forecast, 2018 - 2030 (USD Million)
Table 6 U.S. Nootropics market estimates & forecast, by form (USD Million)
Table 7 U.S. Capsules/Tablets nootropics market estimates and forecast, 2018 - 2030 (USD Million)
Table 8 U.S. Powder nootropics market estimates and forecast, 2018 - 2030 (USD Million)
Table 9 U.S. Drinks nootropics market estimates and forecast, 2018 - 2030 (USD Million)
Table 10 U.S. Gummies nootropics market estimates and forecast, 2018 - 2030 (USD Million)
Table 11 U.S. Other nootropics market estimates and forecast, 2018 - 2030 (USD Million)
Table 12 U.S Nootropics market estimates & forecast, by application (USD Million)
Table 13 U.S. Cognitive Enhance nootropics market estimates and forecast, 2018 - 2030 (USD Million)
Table 14 U.S. Mood & Stress Management nootropics market estimates and forecast, 2018 - 2030 (USD Million)
Table 15 U.S. Sleep Optimization nootropics market estimates and forecast, 2018 - 2030 (USD Million)
Table 16 U.S. Energy & Physical Performance nootropics market estimates and forecast, 2018 - 2030 (USD Million)
Table 17 U.S. others market estimates and forecast, 2018 - 2030 (USD Million)
Table 18 U.S. nootropics market estimates & forecast, by distribution channel (USD Million)
Table 19 U.S. Online nootropics market estimates and forecast, 2018 - 2030 (USD Million)
Table 20 U.S. Offline nootropics market estimates and forecast, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 U.S. Noottopics market snapshot
Fig. 2 U.S. Nootropics market segmentation & scope
Fig. 3 U.S. Nootropics market penetration & growth prospect mapping
Fig. 4 U.S. Nootropics market value chain analysis
Fig. 5 U.S. Nootropics market dynamics
Fig. 6 U.S. Nootropics market Porter's Five Forces analysis
Fig. 7 U.S. Nootropics market: Product movement analysis, 2024 & 2030 (%)
Fig. 8 U.S. Natural nootropics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 9 U.S. Synthetic nootropics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 10 U.S. Nootropics market: Form movement analysis, 2024 & 2030 (%)
Fig. 11 U.S. Capsules/Tablets nootropics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 12 U.S. Powder nootropics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 13 U.S. Drinks nootropics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 14 U.S. Gummies nootropics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 15 U.S. Other nootropics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 16 U.S. Nootropics market: Application movement analysis, 2024 & 2030 (%)
Fig. 17 U.S. Nootropics market estimates and forecast for cognitive enhance, 2018 - 2030 (USD Million)
Fig. 18 U.S. Nootropics market estimates and forecast for mood & stress management, 2018 - 2030 (USD Million)
Fig. 19 U.S. Nootropics market estimates and forecast for sleep optimization, 2018 - 2030 (USD Million)
Fig. 20 U.S. Nootropics market estimates and forecast for energy & physical performance, 2018 - 2030 (USD Million)
Fig. 21 U.S. Nootropics market estimates and forecast for others, 2018 - 2030 (USD Million)
Fig. 22 U.S. Nootropics market: Distribution channel movement analysis, 2024 & 2030 (%)
Fig. 23 U.S. Online nootropics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 U.S. Offline nootropics market estimates and forecast, 2018 - 2030 (USD Million)